We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Latest Generation Coagulation Monitor Boasts Built-in WI-FI Connectivity

By LabMedica International staff writers
Posted on 13 Dec 2015
A new coagulation monitor for professional use combines two critical assays—the activated partial thromboplastin time (aPTT) test and the prothrombin time (PT) test—in a single small, portable instrument.

The medical equipment manufacturer Roche (Basel, Switzerland) recently announced the launch of the CoaguChek Pro II system in countries accepting the CE marking for diagnostic tools. CoaguChek Pro II combines two tests in a single device for greater insight into patients’ coagulation status in acute care settings, such as emergency rooms, operating rooms, intensive care units, or anticoagulation clinics.

Image: The CoaguChek Pro II coagulation monitor (Photo courtesy of Roche).
Image: The CoaguChek Pro II coagulation monitor (Photo courtesy of Roche).

The instrument is small and portable, requiring only a small sample volume of eight microliters to run a full test, and accepts different blood sample types, including capillary blood from a finger prick as well as venous and arterial whole blood. Accuracy and precision of the test strips are guaranteed, since each lot of the test strips is precalibrated against the World Health Organization (WHO) reference method.

The instrument boasts built-in WI-FI connectivity, which allows test results to be transmitted automatically in real time to patients’ electronic health records, ensuring that vital information is immediately available at every point of care.

“Building on the best in class quality, CoaguChek Pro II is small, light, and convenient with accuracy and precision that our customers have come to expect from CoaguChek over the past 20 years,” said Jean-Claude Gottraux, head of professional diagnostics at Roche. “As the latest addition to the CoaguChek family, CoaguChek Pro II expands our coagulation point of care offering beyond self-monitoring and doctors’ offices to also include more specialized settings such as the ER and OR.”

Related Links:

Roche



Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
High-Density Lipoprotein Containing Cholesterol Assay
HDL-c direct FS

Latest Hematology News

New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
13 Dec 2015  |   Hematology

Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
13 Dec 2015  |   Hematology

WBC Count Could Predict Severity of COVID-19 Symptoms
13 Dec 2015  |   Hematology